Phase I Clinical Trial of the Mammalian Target of Rapamycin Inhibitor Everolimus in Combination With Oral Topotecan for Recurrent and Advanced Endometrial Cancer
Carlos Acevedo-Gadea, Alessandro D. Santin, Susan A. Higgins, Shweta Urva, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Peter E. Schwartz, Maysa M. Abu-Khalaf
International Journal of Gynecologic Cancer Mar 2014, 24 (3) 528-533; DOI: 10.1097/IGC.0000000000000085